Autologous Stem cell Transplantation In refractory Crohn’s disease – Low Intensity Therapy Evaluation
Researchers receive grant to better understand how to manage ongoing diarrhoea in stable ulcerative colitis.
Researchers have received £1.5 million of funding from the National Institute for Health Research Health Technology Assessment (NIHR HTA) programme
Applications are invited for grants to be awarded in 2019 by Crohn’s and Colitis UK.
The following prizes were awarded at BSG 2018 in Liverpool
Interested in heading to Vienna for UEG Week 2018? Apply for a BSG bursary to cover your travel expenses!
Five research projects selected to use national clinical audit data to improve health care quality in the UK
Five research projects have been selected by the Health Foundation as part of its £1.6 million open call for research
Guts UK is looking for new members to diversify its Research Awards Committee (RAC)
Every year, the UEG National Societies Committee and the UEG Scientific Committee jointly select 6-8 clinical scientists as 'UEG Rising Stars'.
Guts UK (formerly Core) are pleased to announce the following funding opportunities.
The BSG’s new research strategy sets out our vision to make BSG a world leading and innovative organisation for gastroenterology.
Alcohol screening together with referral or intervention is becoming part of routine practice in England.
The NIHR Nottingham Biomedical Research Centre has become the first in the UK to sign an agreement that could lead to the faster development of new treatments for some of the most common diseases, including arthritis and asthma.
NF-kB signalling is an important cellular pathway implicated in inflammation and cancer.
The Health Research Authority has released further operational guidance on their website for researchers and study coordinators on the implications of GDPR for the delivery of research in the UK.
The primary objective of this study will be to assess whether stabilising gut dysbiosis with FMT in patients with advanced cirrhosis is both feasible and safe.
The new Midlands & Wales research consortium has received funding to a total of £9 million to develop the Midlands & Wales Advanced Therapy Treatment Centre (MW-ATTC).
Researchers receive grant to better understand the effectiveness of amitriptyline as a treatment for IBS in primary care
Researchers have received £1.8 million of funding to conduct a definitive clinical trial of amitriptyline as a treatment for irritable bowel syndrome in primary care.
The aim of this study is to map the management pathway including investigations, biliary decompression and surgery from presentation to 90-day outcome for patients with pancreatic or peri-ampullary cancers as well as those with malignant biliary obstruction.
This year, the award lecture will be delivered by Dr James Lee, Wellcome Trust Intermediate Clinical Fellow and Consultant Gastroenterologist at the University of Cambridge.
This report sets out the funding allocations for the 15 Local Clinical Research Networks (LCRNs) for the financial year 2018/19 and provides a summary of changes made to the CRN funding model.